These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32017027)

  • 1. Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment.
    Tsai TF
    Br J Dermatol; 2020 Jul; 183(1):7-8. PubMed ID: 32017027
    [No Abstract]   [Full Text] [Related]  

  • 2. Management with secukinumab of tumour necrosis factor inhibitor-induced pulmonary sarcoidosis-like reaction in a patient with psoriasis.
    Eichhoff G
    Clin Exp Dermatol; 2020 Jun; 45(4):455-456. PubMed ID: 31541476
    [No Abstract]   [Full Text] [Related]  

  • 3. Secukinumab treatment of tumor necrosis factor antagonists induced paradoxical psoriasis flares in a patient with plaque psoriasis.
    Zheng J; Li Y; Ding Y; Gao Y
    Dermatol Ther; 2020 Nov; 33(6):e14455. PubMed ID: 33107149
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of anti-drug antibodies in patients with psoriasis well-controlled on long-term treatment with tumour necrosis factor inhibitors.
    Meyer MW; Zachariae C; Bendtzen K; Skov L
    Acta Derm Venereol; 2012 Jul; 92(4):362-4. PubMed ID: 22864558
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-interleukin-17 treatment of psoriasis.
    Jinna S; Strober B
    J Dermatolog Treat; 2016 Aug; 27(4):311-5. PubMed ID: 26943806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of nail psoriasis with tumor necrosis factor-alpha blocker agents: an open-label, unblinded, comparative study.
    Ozmen I; Erbil AH; Koc E; Tunca M
    J Dermatol; 2013 Sep; 40(9):755-6. PubMed ID: 23834032
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.
    Viguier M; Aubin F; Delaporte E; Pagès C; Paul C; Beylot-Barry M; Goujon C; Rybojad M; Bachelez H;
    Arch Dermatol; 2012 Dec; 148(12):1423-5. PubMed ID: 23247492
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
    Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
    Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic development in psoriasis.
    Sobell JM; Leonardi CL
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S69-72. PubMed ID: 25268599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis.
    Ahdout J; Haley JC; Chiu MW
    J Am Acad Dermatol; 2010 May; 62(5):874-9. PubMed ID: 19913942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advertisements for TNF Inhibitors.
    Med Lett Drugs Ther; 2008 Nov; 50(1299):89. PubMed ID: 19008788
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic therapy in severe psoriasis pustulosa].
    Valero González S; Díaz de Santiago A; Montero Hernández E; Bilbao Garay J
    Rev Clin Esp; 2009 Sep; 209(8):404-5. PubMed ID: 19775593
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there a benefit from using a subsequent anti-TNF α medication in psoriasis patients who failed their first or second anti-TNF α agent?
    Alsharqi A; Parslew R; Dever B; Arslanian V
    Australas J Dermatol; 2012 May; 53(2):e45-7. PubMed ID: 22571585
    [No Abstract]   [Full Text] [Related]  

  • 14. Paradoxical psoriasis induced by anti-TNF-alpha successfully treated with brodalumab.
    Cortonesi G; Trovato E; Orsini C; Cinotti E; Rubegni P
    Dermatol Ther; 2021 Sep; 34(5):e15084. PubMed ID: 34350674
    [No Abstract]   [Full Text] [Related]  

  • 15. Pregnancy during adalimumab use for psoriasis.
    Dessinioti C; Stefanaki I; Stratigos AJ; Kostaki M; Katsambas A; Antoniou C
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):738-9. PubMed ID: 20569288
    [No Abstract]   [Full Text] [Related]  

  • 16. Secukinumab for treating plaque psoriasis.
    Rothstein B; Gottlieb A
    Expert Opin Biol Ther; 2016; 16(1):119-28. PubMed ID: 26577956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis.
    Capo A; Di Nicola M; Auriemma M; Piaserico S; Cuccurullo C; Santilli F; Davi G; Amerio P
    Eur J Dermatol; 2014; 24(1):133-5. PubMed ID: 24589526
    [No Abstract]   [Full Text] [Related]  

  • 18. Papillary thyroid carcinoma in a patient with severe psoriasis receiving adalimumab.
    Lee JJ; Mann JA; Blauvelt A
    J Am Acad Dermatol; 2011 May; 64(5):999-1000. PubMed ID: 21496712
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry.
    Piaserico S; Cazzaniga S; Chimenti S; Giannetti A; Maccarone M; Picardo M; Peserico A; Naldi L;
    J Am Acad Dermatol; 2014 Feb; 70(2):257-62.e3. PubMed ID: 24355410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 Blockade in Psoriasis.
    Burkett PR; Kuchroo VK
    Cell; 2016 Dec; 167(7):1669. PubMed ID: 27984714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.